Form 4: Oracle CEO Sells 40,000 Shares in Planned Transaction
Insider Transaction Report
Oracle's Chief Executive Officer, Clayton M. Magouyrk, sold 40,000 shares of common stock for approximately $11.06 million under a pre-arranged 10b5-1 trading plan.
Summary
- Clayton M. Magouyrk, Chief Executive Officer of Oracle Corp., reported the sale of 40,000 shares of Oracle common stock.
- The transaction occurred on October 21, 2025.
- The shares were sold at a weighted average price of $276.6377 per share, with individual trades ranging from $276.60 to $276.91.
- The total value of the shares sold is approximately $11,065,508.
- Following this transaction, Magouyrk beneficially owns 154,030 shares of Oracle common stock.
- The sale was executed pursuant to a Rule 10b5-1(c) trading plan.
Sentiment
Score: 5
Explanation: Neutral. The filing reports a pre-scheduled insider stock sale, which is a routine event and does not inherently indicate positive or negative sentiment about the company's future prospects. The use of a 10b5-1 plan mitigates potential negative interpretations.
Positives
- The transaction was conducted under a Rule 10b5-1 trading plan, indicating a pre-scheduled sale and reducing concerns about opportunistic insider trading.
- The reporting person still retains a significant holding of 154,030 shares, demonstrating continued alignment with shareholder interests.
Negatives
- Insider selling, even under a 10b5-1 plan, can sometimes be perceived by the market as a lack of confidence, though this is mitigated by the pre-planned nature.
Risks
- NA
Future Outlook
NA
Industry Context
This Form 4 filing reports a routine insider transaction for Oracle's CEO. Such transactions are common across the technology industry, particularly for executives managing personal finances and diversifying portfolios, often facilitated by Rule 10b5-1 plans to avoid accusations of trading on material non-public information.
Comparison to Industry Standards
- NA
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Insider Trading Policy Adherence | The transaction was made pursuant to a contract, instruction, or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). | 2025-10-21 | This indicates adherence to corporate governance best practices regarding insider trading, as 10b5-1 plans are designed to prevent trading on material non-public information by pre-scheduling transactions. |
Legal Proceedings
- NA
Related Party Transactions
- NA
Stakeholder Impact
- Shareholders: The sale by a key executive might lead to minor market speculation, but the 10b5-1 plan generally reassures investors that the sale is for personal financial planning rather than a reaction to negative company performance. The CEO still holds a substantial number of shares.
Next Steps
- NA
Key Dates
| Date | Description |
|---|---|
| 2025-06-12 | Power of Attorney (POA) filed for Aimee Weast to act on behalf of Clayton M. Magouyrk. |
| 2025-10-21 | Date of transaction where 40,000 shares of common stock were disposed of. |
| 2025-10-23 | Date the Form 4 was signed by the reporting person's attorney-in-fact. |
Keywords
Oracle, ORCL, Clayton M. Magouyrk, CEO, insider trading, stock sale, Form 4, 10b5-1 plan, equity, common stock
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.